FrancophonIA/ELRC3.0 huggingface dataset:
English: Regadenoson shows selectivity (≥ 215-fold) for increasing coronary conductance (A2A-mediated response) relative to slowing of cardiac AV nodal conduction (A1-mediated response) as measured by AV conduction time (rat heart) or the S-H interval (guinea pig heart).
Croatian: Regadenoson je pokazao selektivnost (≥ 215 puta) za povećanje koronarne provodljivosti (odgovor posredovan A2A-receptorima) u odnosu na usporavanje srčane provodnje AV čvora (odgovor posredovan A1-receptorima), dobiveno mjerenjem vremena AV provodnje (srce štakora) ili S-H intervala (srce zamorca).
English: Some people have had flushing, dizziness and increased heart rate when they have been given too much Rapiscan.
Croatian: Kod nekih ljudi pojave se naleti crvenila, omaglica i ubrzani rad srca ako prime previše Rapiscana.
English: You will also be given an injection of sodium chloride 9 mg/ml (0.9%) solution (5 ml), and an injection of a small amount of a radioactive substance (radiopharmaceutical).
Croatian: Također ćete primiti injekciju (5 ml) 0,9%-tne otopine natrijeva klorida (9 mg/ml) i injekciju male količine radioaktivne tvari (radiofarmaceutik).
English: Transient dose dependent increases in heart rate occurred following administration of each dose of regadenoson, whereas no consistent dose-related effect on systolic blood pressure was observed.
Croatian: Do prolaznih, o dozi ovisnih porasta srčane frekvencije došlo je nakon primjene svake doze regadenosona, a nije uočen dosljedni, s dozom povezani učinak na sistolički tlak.
English: It is unknown whether regadenoson is excreted in human breast milk.
Croatian: Nije poznato izlučuje li se regadenoson u majčino mlijeko.
English: Standard catheterisation and FFR measurement techniques are to be followed, and FFR should be measured as the lowest value of Pd/Pa achieved during steady state maximum hyperemia.
Croatian: Potrebno je primijeniti standardnu kateterizaciju i tehnike mjerenja FFR-a, dok FFR treba mjeriti kao najnižu vrijednost
English: In the EXERRT trial the efficacy and safety of regadenoson was evaluated in patients with suboptimal Exercise Stress in an open-label randomized, multi-center, non-inferiority study when regadenoson administered either at 3 minutes during recovery (exercise with regadenoson) or at rest 1 hour later (regadenoson only).
Croatian: Djelotvornost i sigurnost regadenosona je procijenjena u EXERRT studiji u bolesnika s testom suboptimalnog opterećenja tjelesnim naporom u otvorenoj randomiziranoj, muticentričnoj studiji neinferiornosti, u kojoj je regadenoson primijenjen ili u 3 minute tijekom oporavka (vježbanje s regadenosonom), ili u mirovanju 1 sat kasnije (samo regadenoson).
English: Risk of seizure
Croatian: Rizik od konvulzija
English: FFR was measured after IV infusion of adenosine and IV injection of regadenoson (400 μg).
Croatian: FFR je mjeren nakon primjene i.v. infuzije adenozina i i.v. injekcije regadenosona (400 μg).
English: Radionuclide MPI clinical trials conducted with regadenoson excluded patients with recent (within 3 months) myocardial infarction.
Croatian: Klinička ispitivanja slikovne dijagnostike perfuzije miokarda pomoću radionuklida (MPI) provedena s regadenosonom nisu uključivala bolesnike s nedavnim (unutar 3 mjeseca) infarktom miokarda.
English: • discomfort in the stomach
Croatian: • nelagoda u trbuhu
English: Continuous ECG monitoring should be performed and vital signs should be monitored at frequent intervals until the ECG parameters, heart rate and blood pressure have returned to pre-dose levels.
Croatian: Potreban je kontinuirani EKG-monitoring i učestala kontrola vitalnih znakova sve dok se EKG-parametri, srčana frekvencija i krvni tlak ne vrate na vrijednosti prije primjene doze lijeka.
English: The risk of serious hypotension may be higher in patients with autonomic dysfunction, hypovolemia, left main coronary artery stenosis, stenotic valvular heart disease, pericarditis or pericardial effusions, or stenotic carotid artery disease with cerebrovascular insufficiency.
Croatian: Rizik nastanka ozbiljne hipotenzije može biti veći u bolesnika s disfunkcijom autonomnog živčanog sustava, hipovolemijom, stenozom debla lijeve koronarne arterije, stenozirajućom bolešću srčanih zalistaka, perikarditisom ili perikardijalnim izljevom, ili stenozirajućom bolešću karotidnih arterija s cerebrovaskularnom insuficijencijom.
English: The scan uses a radioactive substance called a ‘radiopharmaceutical' to create images.
Croatian: Za stvaranje slike koristi se radioaktivna tvar koju nazivamo "radiofarmaceutik".
English: Water for injections
Croatian: Dinatrijev edetat Voda za injekcije
English: Assessment of adverse reactions for regadenoson is based on safety data from clinical studies and postmarketing experience.
Croatian: Procjena nuspojava regadenosona temelji se na sigurnosnim podacima dobivenim iz kliničkih ispitivanja i iskustvom nakon stavljanja gotovog lijeka na tržište.
English: Very common Electrocardiogram ST segment changes Common
Croatian: Vrlo često promjene ST spojnice na elektrokardiogramu
English: • changes in heart tracing tests (electrocardiogram)
Croatian: • promjene u elektrokardiogramu
English: When possible, dipyridamole should be withheld for at least two days prior to Rapiscan administration (see section 4.5).
Croatian: Ako je to moguće, uzimanje dipiridamola treba prekinuti najmanje dva dana prije primjene Rapiscana (vidjeti dio 4.5).
English: • an allergic reaction which can cause rash, wheals/weals, swelling under the skin near the eyes or throat, throat tightness, and difficulty in breathing may occur immediately or have delayed onset after Rapiscan injection
Croatian: • alergijska reakcija, koja može uzrokovati osip, urtikariju, oticanje potkožnog tkiva oko očiju ili grla, stezanje u grlu i poteškoće s disanjem, može se pojaviti odmah nakon injekcije Rapiscana ili s odgođenim početkom.
English: Activation of the A2A adenosine receptor produces coronary vasodilation and increases coronary blood flow (CBF).
Croatian: Aktivacijom A2A adenozinskih receptora nastupa koronarna vazodilatacija i porast koronarnog protoka krvi.
English: Fractional flow reserve (FFR):
Croatian: Rezerva frakcijskog protoka (FFR):
English: • redness of the skin
Croatian: • crvenilo kože
English: Systolic blood pressure and diastolic blood pressure changes were variable, with the greatest mean change in systolic pressure of −3 mm Hg and in diastolic pressure of −4 mm Hg approximately 1 minute after regadenoson administration.
Croatian: Promjene sistoličkog i dijastoličkog krvnog tlaka bile su promjenljive, s najvećom srednjom promjenom sistoličkog tlaka od −3 mm Hg i dijastoličkog tlaka od −4 mm Hg oko 1 minute nakon primjene regadenosona.
English: In ADVANCE MPI 1 and ADVANCE MPI 2, the following pre-specified safety and tolerability endpoints comparing regadenoson to adenosine achieved statistical significance: (1) a summed score of both the presence and severity of the symptom groups of flushing, chest pain, and dyspnoea was lower with regadenoson (0.9 ± 0.03) than with adenosine (1.3 ± 0.05); and (2) the symptom groups of flushing (21% vs 32%), chest pain (28% vs 40%), and ‘throat, neck or jaw pain' (7% vs 13%) were less frequent with regadenoson ; the incidence of headache (25% vs 16%) was more frequent with regadenoson .
Croatian: U ispitivanjima ADVANCE MPI 1 i ADVANCE MPI 2 sljedeće su prespecificirane mjere ishoda sigurnosti i podnošljivosti bile statistički značajne u usporedbi regadenosona s adenozinom: (1) zbirni rezultat za prisutnost i težinu simptoma u skupinama sa simptomima naleta crvenila, bolova u prsnom košu i dispneje bili su niži za regadenoson (0,9 ± 0,03) nego za adenozin (1,3 ± 0,05); i (2) u skupinama sa simptomima naleta crvenila (21% odnosno 32%), bolova u prsnom košu (28% odnosno 40%), i ‘boli u grlu, vratu i čeljusti' (7% odnosno 13%) bili su manje česti za regadenoson; incidencija glavobolje (25% odnosno 16%) bila je češća za regadenoson.
English: Disodium phosphate dihydrate Sodium dihydrogen phosphate monohydrate Propylene glycol
Croatian: Natrijev hidrogenfosfat dihidrat Natrijev dihidrogenfosfat hidrat Propilenglikol
English: Aminophylline may be used to attenuate severe or persistent adverse reactions to regadenoson.
Croatian: Aminofilin se može primjenjivati za ublažavanje teških ili dugotrajnih nuspojava regadenosona.
English: Regadenoson should be used with caution in patients with a history of atrial fibrillation or flutter.
Croatian: Regadenoson treba primjenjivati s oprezom u bolesnika s ranije poznatim fibrilacijama ili undulacijama atrija.
English: Regadenoson preferentially increases blood flow in coronary relative to peripheral (forelimb, brain, pulmonary) arterial vascular beds in the anaesthetised dog.
Croatian: Regadenoson ima veću sklonost povećanju protoka krvi u koronarkama u odnosu na periferne arterijske vaskularne rezervoare (prednji ekstremitet, mozak, pluća) anesteziranih pasa.
English: Adenosine receptor agonists including regadenoson can depress the sinoatrial (SA) and AV nodes and may cause first, second or third degree AV block, or sinus bradycardia.
Croatian: Agonisti adenozinskih receptora uključujući regadenoson mogu deprimirati sinoatrijski (SA) i AV čvor i uzrokovati AV blok prvog, drugog i trećeg stupnja ili sinus bradikardiju.
English: The pharmacokinetic parameters of regadenoson have not been specifically evaluated in those with varying degrees of hepatic impairment.
Croatian: Farmakokinetički parametri regadenosona nisu još specifično procijenjeni u bolesnika s promjenjivim stupnjevima oštećenja funkcije jetre.
English: In clinical trials first degree AV block (PR prolongation > 220 msec) developed in 3% of patients within 2 hours of regadenoson administration; transient second degree AV block with one dropped beat was observed in one patient receiving regadenoson.
Croatian: U kliničkim ispitivanjima AV blok prvog stupnja (produženi PR interval > 220 msek) razvio se u 3% bolesnika unutar 2 sata od primjene regadenosona; prolazni AV blok drugog stupnja s neprovedenim jednim QRS-om primijećen je kod jednog bolesnika koji je primio regadenoson.
English: When possible, dipyridamole should be withheld for at least two days prior to regadenoson administration (see section 4.2).
Croatian: Ako je to moguće, uzimanje dipiridamola treba prekinuti najmanje dva dana prije primjene regadenosona (vidjeti dio 4.2).
English: Patients should avoid consumption of any medicinal products containing methylxanthines as well as any medicinal products containing theophylline for at least 12 hours before regadenoson administration (see section 4.2).
Croatian: Bolesnici trebaju izbjegavati konzumaciju lijekova koji sadrže metilksantine, kao i bilo koji lijek koji sadrži teofilin, najmanje 12 sati prije primjene regadenosona (vidjeti dio 4.2).
English: The most common adverse reactions reported during clinical development in a total of 1,651 patients/subjects were: dyspnoea (29%), headache (27%), flushing (23%), chest pain (19%), electrocardiogram ST segment changes (18%), gastrointestinal discomfort (15%) and dizziness (11%).
Croatian: Najčešće prijavljene nuspojave tijekom kliničkog razvoja lijeka na ukupno 1651 bolesniku/ispitaniku bile su: dispneja (29%), glavobolja (27%), naleti crvenila (23%), bol u prsnom košu (19%), promjene ST spojnice na elektrokardiogramu (18%), nelagoda u gastrointestinalnom traktu (15%) i omaglica (11%).
English: The doctor performing the catheterisation may also want to measure the difference in pressure (fractional flow reserve) due to a narrowing detected in one or more arteries of the heart.
Croatian: Liječnik koji provodi kateterizaciju može također željeti izmjeriti razliku u tlaku (rezerva frakcijskog protoka) zbog suženja otkrivenog u jednoj ili više srčanih arterija.
English: In the first and second studies, dyspnoea was reported as an adverse reaction following regadenoson dosing (61% for patients with COPD; 34% for patients with asthma) while no subjects experienced dyspnoea following placebo dosing.
Croatian: U prvom i drugom ispitivanju dispneja kao nuspojava prijavljena je nakon primjene doze Rapiscana (61% bolesnika s KOPB; 34% bolesnika s astmom), dok nije prijavljena u ispitanika koji su primili dozu placeba.
English: During catheterisation of the arteries of the heart, your doctor may measure the pressure difference (also known as fractional flow reserve - FFR) due to a narrowing in one or more arteries of the heart.
Croatian: Tijekom kateterizacije arterija srca liječnik može izmjeriti razliku u tlaku (također poznatu i kao rezerva frakcijskog protoka - engl. fractional flow reserve, FFR) zbog suženja jedne ili više srčanih arterija.
English: Regadenoson administration may result in adverse reactions such as dizziness, headache, and dyspnoea (see section 4.8) soon after administration.
Croatian: Primjena regadenosona može imati za posljedicu pojavu nuspojava poput omaglice, glavobolje i dispneje (vidjeti dio 4.8) ubrzo nakon primjene.
English: The most common cardiovascular histories included hypertension (81%), coronary artery bypass graft (CABG), percutaneous transluminal coronary angioplasty (PTCA) or stenting (51%), angina (63%), and history of myocardial infarction (41%) or arrhythmia (33%); other medical history included diabetes (32%) and COPD (5%).
Croatian: Najčešće kardiovaskularne bolesti u anamnezi bile su hipertenzija (81%), aortokoronarno premoštenje (CABG), perkutana transluminalna koronarna angioplastika (PTCA) ili postavljeni stentovi (51%), angina pectoris (63%), te preboljeli infarkt miokarda (41%) ili aritmija (33%); ostale bolesti iz anamneze uključivale su dijabetes (32%) i KOPB (5%).
English: Study
Croatian: Studija
English: Fertility and pre- and post-natal studies have not been conducted.
Croatian: Ispitivanja utjecaja na plodnost, prenatalni i postnatalni razvoj nisu provedena.
English: In clinical trials, decreased systolic blood pressure (> 35 mm Hg) was observed in 7% of patients and decreased diastolic blood pressure (> 25 mm Hg) was observed in 4% of patients within 45 minutes of regadenoson administration.
Croatian: U kliničkim ispitivanjima sniženje sistoličkog krvnog tlaka (> 35 mm Hg) primijećeno je u 7% bolesnika, a sniženje dijastoličkog krvnog tlaka (> 25 mm Hg) primijećeno je u 4% bolesnika unutar 45 minuta od primjene regadenosona.
English: Regadenoson, can depress the SA and AV nodes and may cause first, second or third degree AV block, or sinus bradycardia requiring intervention.
Croatian: Regadenoson može deprimirati SA i AV čvor i uzrokovati AV blok prvog, drugog ili trećeg stupnja ili sinus bradikardiju koja zahtijeva intervenciju.
English: Adenosine receptor agonists including regadenoson induce arterial vasodilation and hypotension.
Croatian: Agonisti adenozinskih receptora uključujući regadenoson izazivaju arterijsku vazodilataciju i hipotenziju.
English: Each 5 ml vial of Rapiscan contains 400 micrograms of regadenoson.
Croatian: Jedna bočica od 5 ml Rapiscana sadrži 400 mikrograma regadenosona.
English: After the initial scan, patients were randomised to either regadenoson or adenosine, and received a second stress scan with the same radionuclide imaging protocol as that used for the initial scan.
Croatian: Nakon inicijalnog snimanja bolesnici su randomizirani u skupinu koja će primiti regadenoson odnosno adenozin, te je učinjeno drugo snimanje pod stresom koristeći isti protokol snimanja pomoću radionuklida kao i kod prvog snimanja.
English: The baseline MPI scan at rest, and the MPI scans for the exercise with regadenoson and regadenoson only groups constituted the MPI 1 phase.
Croatian: Početni MPI sken u mirovanju i MPI skenovi za skupinu koja je vježbala s regadenosonom i skupinu samo s regadenosonom predstavljaju MPI 1 fazu.
English: Warnings related to excipients
Croatian: Upozorenja koja se odnose na pomoćne tvari
English: In ADVANCE MPI 1 and ADVANCE MPI 2, the Cicchetti-Allison and Fleiss-Cohen weighted kappas of the median score of three blinded readers with respect to ischaemia size category (not counting segments with normal rest uptake and mild/equivocal reduction in stress uptake as ischaemic) for the combined studies of regadenoson with the adenosine scan were moderate, 0.53 and 0.61, respectively;
Croatian: U ispitivanjima ADVANCE MPI 1 i ADVANCE MPI 2, Cicchetti-Allisonov i Fleiss-Cohenov ponderirani kapa koeficijent za medijan rezultata tri slijepa čitača, uzimajući u obzir kategoriju veličine ishemije (ne računajući pritom segmente s normalnom apsorpcijom radionuklida u mirovanju, a s blagom/nejasnom redukcijom preuzimanja radionuklida u naporu kao ishemičke), u kombiniranom ispitivanju snimaka učinjenih primjenom regadenosona i adenozina bili su umjereni (0,53 odnosno 0,61); jednako tako bili su ponderirani kapa koeficijenti za dvije uzastopne snimke učinjene primjenom adenozina, 0,50 odnosno 0,55.
English: Adenosine receptor agonists, including regadenoson induce arterial vasodilation and hypotension.
Croatian: Agonisti adenozinskih receptora uključujući regadenoson uzrokuju arterijsku vazodilataciju i hipotenziju.
English: In the second study in 48 patients with mild to moderate asthma who had previously been shown to have bronchoconstrictive reactions to adenosine monophosphate, the rate of FEV1 reduction > 15% from baseline was the same (4%) following both regadenoson and placebo dosing.
Croatian: U drugom ispitivanju na 48 bolesnika s blagom do umjerenom astmom koji su ranije reagirali bronhokonstrikcijom na adenozinmonofosfat, stopa smanjenja FEV1 > 15% od početnih vrijednosti bila je jednaka (4%) i nakon primjene regadenosona i nakon placeba.
English: In clinical trials, increased systolic blood pressure (≥ 50 mm Hg) was observed in 0.7% of patients and increased diastolic blood pressure (≥ 30 mm Hg) in 0.5% of patients.
Croatian: U kliničkim ispitivanjima povišenje sistoličkog krvnog tlaka (≥ 50 mm Hg) primijećeno je u 0,7% bolesnika, a povišenje dijastoličkog krvnog tlaka (≥ 30 mm Hg) primijećeno je u 0,5% bolesnika.
English: Rapiscan contains sodium
Croatian: Rapiscan sadrži natrij
English: Pack size of 1.
Croatian: Pakiranje od 1 bočice.
English: Intravenous use.
Croatian: Intravenska primjena.
English: In the third study in 1009 patients with mild or moderate asthma (n=537) and moderate or severe COPD (n=472) the incidence of FEV1 reduction >15% from baseline was 1.1% and 2.9% in patients with asthma (p=0.15) and 4.2% and 5.4% in patients with COPD (p=0.58) following regadenoson and placebo dosing, respectively.
Croatian: U trećem ispitivanju na 1009 bolesnika s blagom do umjerenom astmom (n=537) i umjerenom do teškom KOPB (n=472) incidencija smanjenja FEV1 >15% od polaznih vrijednosti bila je 1,1% odnosno 2,9% u bolesnika s astmom (p=0,15) i 4,2% odnosno 5,4% u bolesnika s KOPB (p=0,58) nakon primjene doze regadenosona odnosno placeba.
English: Very common Headache, dizziness Common
Croatian: Vrlo često glavobolja, omaglica
English: Common side effects (affects 1 to 10 users in 100)
Croatian: Česte nuspojave (pojavljuju se kod 1 do 10 bolesnika na 100)
English: The pharmacokinetics of regadenoson in patients on dialysis has not been assessed.
Croatian: Farmakokinetika regadenosona u bolesnika na dijalizi još nije ispitana.
English: For use in FFR: This product is to be administered no more than twice, no less than10 minutes apart, during any 24 hour period.
Croatian: Za primjenu u FFR-u: Rapiscan se ne smije primijeniti više od dva puta tijekom bilo kojeg razdoblja od 24 sata, a razmak između primjena mora biti najmanje 10 minuta.
English: • respiratory arrest
Croatian: • zastoj disanja
English: After you have been given Rapiscan, you will be given an injection of sodium chloride 9 mg/ml (0.9%) solution which contains 45 mg of sodium.
Croatian: Nakon što primite Rapiscan primit ćete injekciju 0,9%-tne otopine natrijeva klorida (9 mg/ml) koja sadrži 45 mg natrija.
English: In postmarketing experience, third degree heart block and asystole have been reported within minutes of regadenoson administration.
Croatian: Nakon stavljanja regadenosona na tržište prijavljena je pojava bloka trećeg stupnja i asistolije unutar nekoliko minuta od njegove primjene.
English: Fatal cardiac arrest, life-threatening ventricular arrhythmias and myocardial infarction may result from the ischaemia induced by pharmacologic stress agents.
Croatian: Fatalni kardijalni zastoj, po život opasne ventrikularne aritmije i infarkt miokarda mogu biti posljedica ishemije inducirane farmakološkim stresnim agensima.
English: • sudden stopping of the heart or damage to the heart, heart block (a disorder of the heart's electrical signal, where the signal cannot pass from the upper to the lower chambers), slow heart beat
Croatian: • iznenadni prestanak rada srca ili njegovo oštećenje, srčani blok (poremećaj srčanog električnog impulsa, kada signal ne može prijeći s pretklijetki na klijetke), usporeni srčani otkucaji
English: The most common cardiovascular conditions were patients with a medical history of hypertension, dyslipidemia / hypercholesterolemia, diabetes mellitus, smoking, prior PCI and prior MI.
Croatian: Kao najčešća kardiovaskularna stanja bolesnici su u anamnezi imali hipertenziju, dislipidemiju/ hiperkolesterolemiju, diabetes melitus, pušenje, raniji PCI (engl. percutaneous coronary intervention) i raniji infarkta miokarda.
English: Use of regadenoson involving exercise has been associated with serious adverse reactions including hypotension, hypertension, syncope and cardiac arrest.
Croatian: Primjena regadenosona uz tjelesni napor povezana je s ozbiljnim nuspojavama uključujući hipotenziju, hipertenziju, sinkopu i kardijalni zastoj.
English: The agreement rate for the image obtained with regadenoson or adenosine relative to the initial adenosine image was calculated by determining how frequently the patients assigned to each initial adenosine category (0-1, 2-4, 5-17 reversible segments) were placed in the same category with the randomised scan.
Croatian: Stopa podudarnosti nalaza snimaka dobivenih uz primjenu regadenosona ili adenozina u odnosu na inicijalne snimke dobivene uz primjenu adenozina izračunata je određivanjem učestalosti kojom su bolesnici iz svake inicijalne kategorije u skupini adenozina (0-1, 2-4, 5-17 segmenata reverzibilnog defekta perfuzije) svrstavani u istu kategoriju nakon randomiziranih snimanja.
English: Very common side effects (affects more than 1 user in 10)
Croatian: Vrlo česte nuspojave (pojavljuju se kod više od 1 na 10 bolesnika)
English: This makes more blood flow to the muscles of the heart.
Croatian: Time se povećava protok krvi u srčanom mišiću.
English: Solution for injection Clear, colourless solution.
Croatian: Otopina za injekciju Bistra, bezbojna otopina.
English: • sudden stopping of the heart or damage to the heart, heart block (a disorder of the heart's electrical signal, where the signal cannot pass from the upper to the lower chambers), rapid heart beat
Croatian: • iznenadni prestanak rada srca ili njegovo oštećenje, srčani blok (poremećaj srčanog električnog impulsa, kada signal ne može prijeći s pretklijetki na klijetke), ubrzane srčane otkucaje
English: Do not use Rapiscan after the expiry date which is stated on the vial and carton after EXP.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na bočici i kutiji iza oznake „Rok valjanosti“ ili “EXP”.
English: Therefore administration of aminophylline solely for the purpose of terminating a seizure induced by regadenoson is not recommended.
Croatian: Stoga se ne preporučuje primjena aminofilina isključivo u svrhu zaustavljanja konvulzija izazvanih regadenosonom.
English: Rapiscan must not be used if the solution if it is discoloured or particulate matter is present.
Croatian: Rapiscan se ne smije upotrijebiti ako primijetite da je otopina promijenila boju ili sadrži čestice.
English: The active substance in Rapiscan is regadenoson.
Croatian: Djelatna tvar Rapiscana je regadenoson.
English: Radionuclide myocardial perfusion imaging (MPI):
Croatian: Slikovna dijagnostika perfuzije miokarda pomoću radionuklida (MPI):